Literature DB >> 28259682

Cross-Cultural Validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).

Robert F Ofenloch1, Jart A F Oosterhaven2, Päivikki Susitaival3, Åke Svensson4, Elke Weisshaar5, Keiko Minamoto6, Meltem Onder7, Marie Louise A Schuttelaar2, Emel Bulbul Baskan8, Thomas L Diepgen5, Christian Apfelbacher9.   

Abstract

The Quality of Life in Hand Eczema Questionnaire (QOLHEQ) is the only instrument assessing disease-specific health-related quality of life in patients with hand eczema. It is available in eight language versions. In this study we assessed if the items of different language versions of the QOLHEQ yield comparable values across countries. An international multicenter study was conducted with participating centers in Finland, Germany, Japan, The Netherlands, Sweden, and Turkey. Methods of item response theory were applied to each subscale to assess differential item functioning for items among countries. Overall, 662 hand eczema patients were recruited into the study. Single items were removed or split according to the item response theory model by country to resolve differential item functioning. After this adjustment, none of the four subscales of the QOLHEQ showed significant misfit to the item response theory model (P < 0.01), and a Person Separation Index of greater than 0.7 showed good internal consistency for each subscale. By adapting the scoring of the QOLHEQ using the methods of item response theory, it was possible to obtain QOLHEQ values that are comparable across countries. Cross-cultural variations in the interpretation of single items were resolved. The QOLHEQ is now ready to be used in international studies assessing the health-related quality of life impact of hand eczema.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28259682     DOI: 10.1016/j.jid.2017.02.969

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Cross-cultural measurement invariance of the Quality of Life Enjoyment and Satisfaction Questionnaire-Short form across ten countries: the application of Bayesian approximate measurement invariance.

Authors:  Zahra Bagheri; Parisa Chamanpara; Peyman Jafari; Yatan Pal Singh Balhara; Sidharth Arya; Ramdas Ransing; Ana Đorić; Rajna Knez; Tuong-Vi Vu Thi; Truong Ngoc Huong; Helin Yilmaz Kafali; Gamze Erzin; Zahir Vally; Mita Rani Roy Chowdhury; Pawan Sharma; Rabi Shakya; Luís Antônio Monteiro Campos; Anna Rebeka Szczegielniak; Dejan Stevanović
Journal:  BMC Psychol       Date:  2022-06-24

2.  Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ).

Authors:  J A F Oosterhaven; R F Ofenloch; M L A Schuttelaar
Journal:  Br J Dermatol       Date:  2019-11-24       Impact factor: 9.302

Review 3.  Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.

Authors:  Amy Barrett; Julie Hahn-Pedersen; Nana Kragh; Emily Evans; Ari Gnanasakthy
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

Review 4.  Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Authors:  Ester Di Agosta; Lorenzo Salvati; Monica Corazza; Ilaria Baiardini; Francesca Ambrogio; Luisa Angileri; Elettra Antonelli; Federica Belluzzo; Domenico Bonamonte; Laura Bonzano; Raffaele Brancaccio; Paolo Custurone; Aurora De Marco; Aikaterini Detoraki; Adriana Di Guida; Elisabetta Di Leo; Marta Fantò; Filippo Fassio; Silvia Mariel Ferrucci; Caterina Foti; Rosella Gallo; Alessia Gatta; Fabrizio Guarneri; Lucia Guidolin; Katharina Hansel; Donatella Lamacchia; Carla Lombardo; Paola Lucia Minciullo; Maddalena Napolitano; Alessandro Pannofino; Andrea Paravisi; Roberta Parente; Maria Passante; Cataldo Patruno; Diego Peroni; Cristina Quecchia; Natale Schettini; Giuseppe Spadaro; Luca Stingeni; Daniele Tarrini; Marta Tramontana; Eustachio Nettis; Oliviero Rossi
Journal:  Clin Mol Allergy       Date:  2021-12-20

5.  Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.

Authors:  Jart Ate Franke Oosterhaven; Marie Louise Anna Schuttelaar
Journal:  BMJ Open       Date:  2018-07-11       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.